Merit Medical Systems, Inc. $MMSI Shares Acquired by Westwood Holdings Group Inc.

Westwood Holdings Group Inc. lifted its stake in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 11.9% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 768,970 shares of the medical instruments supplier’s stock after buying an additional 81,469 shares during the period. Westwood Holdings Group Inc. owned approximately 1.30% of Merit Medical Systems worth $71,883,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Maseco LLP purchased a new position in shares of Merit Medical Systems during the second quarter worth about $28,000. MassMutual Private Wealth & Trust FSB boosted its position in shares of Merit Medical Systems by 55.6% in the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 375 shares of the medical instruments supplier’s stock valued at $35,000 after purchasing an additional 134 shares during the period. Northwestern Mutual Wealth Management Co. grew its stake in Merit Medical Systems by 119.8% during the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 367 shares of the medical instruments supplier’s stock worth $39,000 after buying an additional 200 shares during the last quarter. Bayforest Capital Ltd acquired a new position in Merit Medical Systems during the first quarter worth approximately $41,000. Finally, EverSource Wealth Advisors LLC lifted its stake in Merit Medical Systems by 745.9% in the second quarter. EverSource Wealth Advisors LLC now owns 922 shares of the medical instruments supplier’s stock valued at $86,000 after buying an additional 813 shares during the last quarter. 99.66% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Merit Medical Systems

In related news, Chairman Fred P. Lampropoulos sold 10,000 shares of the company’s stock in a transaction on Tuesday, November 25th. The stock was sold at an average price of $88.04, for a total transaction of $880,400.00. Following the transaction, the chairman owned 1,019,955 shares of the company’s stock, valued at $89,796,838.20. This represents a 0.97% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Insiders sold 60,000 shares of company stock valued at $5,189,900 in the last quarter. 3.20% of the stock is owned by insiders.

Merit Medical Systems Stock Up 0.2%

Shares of NASDAQ:MMSI opened at $86.70 on Friday. Merit Medical Systems, Inc. has a fifty-two week low of $78.12 and a fifty-two week high of $111.45. The company has a quick ratio of 2.86, a current ratio of 4.28 and a debt-to-equity ratio of 0.48. The firm’s 50-day simple moving average is $84.70 and its 200-day simple moving average is $87.36. The company has a market cap of $5.14 billion, a price-to-earnings ratio of 44.46, a PEG ratio of 2.77 and a beta of 0.61.

Merit Medical Systems (NASDAQ:MMSI) last announced its quarterly earnings data on Thursday, October 30th. The medical instruments supplier reported $0.92 EPS for the quarter, beating analysts’ consensus estimates of $0.82 by $0.10. Merit Medical Systems had a net margin of 8.02% and a return on equity of 14.27%. The firm had revenue of $384.16 million during the quarter, compared to the consensus estimate of $371.69 million. During the same quarter last year, the firm earned $0.86 earnings per share. The firm’s revenue was up 13.0% compared to the same quarter last year. Merit Medical Systems has set its FY 2025 guidance at 3.660-3.790 EPS. As a group, equities research analysts predict that Merit Medical Systems, Inc. will post 3.37 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on MMSI. Needham & Company LLC restated a “buy” rating and set a $108.00 target price on shares of Merit Medical Systems in a research report on Friday, October 31st. Robert W. Baird set a $103.00 price objective on shares of Merit Medical Systems in a research report on Friday, October 31st. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Merit Medical Systems in a report on Monday, December 8th. Canaccord Genuity Group decreased their target price on shares of Merit Medical Systems from $104.00 to $93.00 and set a “buy” rating for the company in a research note on Friday, November 14th. Finally, Zacks Research lowered Merit Medical Systems from a “strong-buy” rating to a “hold” rating in a report on Tuesday, November 18th. Eight equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $104.50.

Merit Medical Systems Profile

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.